A reappraisal of brush cytology for screening of Barrett’s esophagus

References

• 1 Fahmy M, Skacel M, Gramlich T. et al . Chromosomal gains and genomic loss of p53 and p16 genes in Barrett’s esophagus detected by flourescence in situ hybridization of cytology specimens.  Modern Pathology. 2004;  17 588-596
• 2 Zagorowicz E, Jankowski J. Molecular changes in the progression of Barrett’s oesophagus. Systematic review of molecular biomarkers, regarding the ASPECT study in the UK.  Post Grad Med J. 2007;  83 529-535
• 3 Tischoff I, Tannapfel A. Barrett’s esophagus: can biomarkers predict progression to malignancy?.  Expert Rev Gastroenterol Hepatol. 2008;  2 653-663
• 4 Saad S R, Mahood K L, Clary M K. et al . Role of cytology in the diagnosis of Barretts esophagus and associated neoplasia.  Diagn Cytopathol. 2003;  29 130-135
• 5 Huang Q, Hardie L J. Biomarkers in Barrett’s oesophagus.  Biochemical Society Transaction. 2010;  38 343-347
• 6 Spechler S J. Clinical practice. Barrett’s Esophagus.  N Engl J Med. 2002;  346 836-842
• 7 Kumaravel A, Lopez R, Brainard J, Falk G W. Brush cytology vs. endoscopic biopsy for the surveillance of Barrett’s esophagus.  Endoscopy. 2010;  10 800-805
• 8 Geisinger K R, Teot L A, Richter J E. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett’s esophagus.  Cancer. 1992;  69 8-16
• 9 Robey S S, Hamilton S R, Gupta P K, Erozan Y S. Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma.  Am J Clin Pathol. 1988;  89 493-498
• 10 Hardwick R H, Morgan R J, Warren B F. et al . Brush cytology in the diagnosis of neoplasia in Barrett’s esophagus.  Dis Esophagus. 1997;  10 233-237
• 11 Fritcher E G, Brankley S M, Kipp B R. et al . A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett’s esophagus.  Hum Pathol. 2008;  39 1128-1135
• 12 Falk G W. Cytology in Barrett’s esophagus.  Gastrointest Endosc Clin N Am. 2003;  13 335-348
• 13 Falk G W, Chittajallu R, Goldblum J R. et al . Surveillance of patients with Barrett’s esophagus for dysplasia and cancer with balloon cytology.  Gastroenterology. 1997;  112 1787-1797
• 14 Brankley S, Wang K K, Harwood A R. et al . The development of a flourescence in situ hybridisation assay for the detection of dysplasia and adenocarcinoma in Barrett’s esophagus.  J Mol Diagn. 2006;  8 260-267
• 15 Rygiel A, van Baal W, Milano F. et al . Efficient automated assessment of genetic abnormalities detected by flourescent in situ hybridization on brush cytology of a Barrett’s esophagus surveillance population.  Cancer. 2007;  109 1980-1988
• 16 Rygiel A, van Baal W, Milano F. et al . Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett’s esophagus brush cytology specimens.  Genes Chromosomes Cancer. 2008;  47 396-404
• 17 Kerkhof M, Kusters J, van Dekken H. et al . Biomarkers for risk stratification of neoplastic progression in Barrett esophagus.  Cell Oncol. 2007;  29 507-517